Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Int J Biol Sci 2014; 10(4):404-414. doi:10.7150/ijbs.7723 This issue Cite

Research Paper

Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma

Qian-Qian Zhang1*, Yi Ding1*, Yan Lei1, Cui-Ling Qi1, Xiao-Dong He1, Tian Lan1, Jiang-Chao Li1, Ping Gong1, Xuesong Yang3, Jian-Guo Geng2✉, Li-Jing Wang1✉

1. Vascular Biology Research Institute, Guangdong Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China.
2. Department of Biologic and Materials Sciences, University of Michigan School of Dentistry, Ann Arbor, MI 48109, USA.
3. Department of Histology and Embryology, Key Laboratory for Regenerative Medicine of the Ministry of Education, Medical College of Jinan University, Guangzhou 510632, China.
* These authors contributed equally to this work.

✉ Corresponding author: Li-Jing Wang, phone: 86-20-39352231, fax: 86-20-39352397, wanglijingedu.cn; and Jian-Guo Geng, phone: 86-20-39352231, fax: 86-20-39352397, genglabcom.

Citation:
Zhang QQ, Ding Y, Lei Y, Qi CL, He XD, Lan T, Li JC, Gong P, Yang X, Geng JG, Wang LJ. Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci 2014; 10(4):404-414. doi:10.7150/ijbs.7723. https://www.ijbs.com/v10p0404.htm
Other styles

File import instruction

Abstract

Insulinomas are rare tumors, and approximately 10% of insulinomas are malignant. Accumulating evidence has implicated that we still lack effective therapy to treat the patients who are diagnosed with rare malignant insulinoma. Previous studies have reported that Andrographolide (Andro) could inhibit cell cycle progression, reduce cell invasion and induce cell apoptosis in many common cancer cells. However, the effects of andro are cell type-dependent. So we emplored the β-TC-6 cells and the RIP1-Tag2 transgenic mouse model of endogenously growing insulinoma model to elucidate the possible anti-cancer effect of Andro on insulinoma, an uncommon type of malignant cancers in this study. Our experiments revealed that Andro significantly inhibited tumor growth at both the early-stage and the advanced-stage of insulinoma through targeting the TLR4/NF-κB signaling pathway. This work initially provides the evidence that the TLR4/NF-κB signaling pathway might be vital as a potential therapeutic target, and also indispensable in Andro-mediated anti-cancer effect in insulinoma.

Keywords: Andrographolide, insulinoma, growth.

Citation styles

APA
Zhang, Q.Q., Ding, Y., Lei, Y., Qi, C.L., He, X.D., Lan, T., Li, J.C., Gong, P., Yang, X., Geng, J.G., Wang, L.J. (2014). Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. International Journal of Biological Sciences, 10(4), 404-414. https://doi.org/10.7150/ijbs.7723.

ACS
Zhang, Q.Q.; Ding, Y.; Lei, Y.; Qi, C.L.; He, X.D.; Lan, T.; Li, J.C.; Gong, P.; Yang, X.; Geng, J.G.; Wang, L.J. Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int. J. Biol. Sci. 2014, 10 (4), 404-414. DOI: 10.7150/ijbs.7723.

NLM
Zhang QQ, Ding Y, Lei Y, Qi CL, He XD, Lan T, Li JC, Gong P, Yang X, Geng JG, Wang LJ. Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci 2014; 10(4):404-414. doi:10.7150/ijbs.7723. https://www.ijbs.com/v10p0404.htm

CSE
Zhang QQ, Ding Y, Lei Y, Qi CL, He XD, Lan T, Li JC, Gong P, Yang X, Geng JG, Wang LJ. 2014. Andrographolide Suppress Tumor Growth by Inhibiting TLR4/NF-κB Signaling Activation in Insulinoma. Int J Biol Sci. 10(4):404-414.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) License. See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use